Swisher Daniel N JR 4
4 · CORCEPT THERAPEUTICS INC · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Swisher Daniel N JR
Director
Transactions
- Exercise/Conversion
Common Stock
2025-06-10$14.08/sh+2,200$30,976→ 2,200 total - Exercise/Conversion
Stock option (right to buy)
2025-06-10−2,200→ 9,900 totalExercise: $14.08Exp: 2028-08-20→ Common Stock (2,200 underlying) - Sale
Common Stock
2025-06-10$70.61/sh−2,200$155,342→ 0 total - Award
Stock option (right to buy)
2025-06-10+15,000→ 15,000 totalExercise: $72.27Exp: 2035-06-10→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
- [F2]Fully exercisable.
- [F3]Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.